These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Nasolacrimal ducts and the dry eye]. Paulsen F; Thale A; Schaudig U Ophthalmologe; 2002 Jul; 99(7):566-74. PubMed ID: 12148305 [TBL] [Abstract][Full Text] [Related]
7. The cavernous body of the human efferent tear ducts: function in tear outflow mechanism. Paulsen FP; Thale AB; Hallmann UJ; Schaudig U; Tillmann BN Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):965-70. PubMed ID: 10752929 [TBL] [Abstract][Full Text] [Related]
8. Functional anatomy of the human efferent tear ducts: a new theory of tear outflow mechanism. Thale A; Paulsen F; Rochels R; Tillmann B Graefes Arch Clin Exp Ophthalmol; 1998 Sep; 236(9):674-8. PubMed ID: 9782428 [TBL] [Abstract][Full Text] [Related]
9. [Tear outflow. Impact of mucins and TFF-peptides]. Paulsen F; Corfield A; Hinz M; Hoffmann W; Schaudig U; Thale A; Berry M Ophthalmologe; 2004 Jan; 101(1):19-24. PubMed ID: 14872263 [TBL] [Abstract][Full Text] [Related]
10. Characterization of mucins in human lacrimal sac and nasolacrimal duct. Paulsen FP; Corfield AP; Hinz M; Hoffmann W; Schaudig U; Thale AB; Berry M Invest Ophthalmol Vis Sci; 2003 May; 44(5):1807-13. PubMed ID: 12714609 [TBL] [Abstract][Full Text] [Related]
11. [Anatomy and physiology of the nasolacrimal ducts]. Paulsen F; Garreis F; Schicht M; Bräuer L; Ali MJ; Sel S HNO; 2016 Jun; 64(6):354-66. PubMed ID: 27240791 [TBL] [Abstract][Full Text] [Related]
12. Cell and molecular biology of human lacrimal gland and nasolacrimal duct mucins. Paulsen F Int Rev Cytol; 2006; 249():229-79. PubMed ID: 16697285 [TBL] [Abstract][Full Text] [Related]
13. TFF peptides in the human efferent tear ducts. Paulsen FP; Hinz M; Schaudig U; Thale AB; Hoffmann W Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3359-64. PubMed ID: 12407144 [TBL] [Abstract][Full Text] [Related]
14. Loss of tear duct-associated lymphoid tissue in association with the scarring of symptomatic dacryostenosis. Paulsen FP; Schaudig U; Maune S; Thale AB Ophthalmology; 2003 Jan; 110(1):85-92. PubMed ID: 12511351 [TBL] [Abstract][Full Text] [Related]
15. Innervation of the cavernous body of the human efferent tear ducts and function in tear outflow mechanism. Paulsen F; Hallmann U; Paulsen J; Thale A J Anat; 2000 Aug; 197 ( Pt 2)(Pt 2):177-87. PubMed ID: 11005710 [TBL] [Abstract][Full Text] [Related]
16. The cavernous body of the human efferent tear ducts contributes to regulation of tear outflow. Ayub M; Thale AB; Hedderich J; Tillmann BN; Paulsen FP Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4900-7. PubMed ID: 14578415 [TBL] [Abstract][Full Text] [Related]
17. Lacrimal drainage-associated lymphoid tissue (LDALT): a part of the human mucosal immune system. Knop E; Knop N Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):566-74. PubMed ID: 11222512 [TBL] [Abstract][Full Text] [Related]
18. Tricompartment model of the lacrimal pump mechanism. Becker BB Ophthalmology; 1992 Jul; 99(7):1139-45. PubMed ID: 1495795 [TBL] [Abstract][Full Text] [Related]
19. Detection of surfactant proteins A and D in human tear fluid and the human lacrimal system. Bräuer L; Kindler C; Jäger K; Sel S; Nölle B; Pleyer U; Ochs M; Paulsen FP Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):3945-53. PubMed ID: 17724171 [TBL] [Abstract][Full Text] [Related]